CHOLESTYRAMINE (cholestyramine) by Teva is bile-acid binding activity [moa]. Approved for hypertension. First approved in 2020.
Drug data last refreshed 1w ago
Bile-acid Binding Activity
Bile Acid Sequestrant
A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease
Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale
Worked on CHOLESTYRAMINE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.